![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NOP56 |
Gene summary for NOP56 |
![]() |
Gene information | Species | Human | Gene symbol | NOP56 | Gene ID | 10528 |
Gene name | NOP56 ribonucleoprotein | |
Gene Alias | NOL5A | |
Cytomap | 20p13 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | O00567 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10528 | NOP56 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.68e-03 | 4.04e-01 | -0.0811 |
10528 | NOP56 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.04e-03 | 2.70e-01 | -0.1954 |
10528 | NOP56 | HTA11_1391_2000001011 | Human | Colorectum | AD | 4.56e-08 | 6.17e-01 | -0.059 |
10528 | NOP56 | HTA11_866_3004761011 | Human | Colorectum | AD | 2.23e-08 | 4.85e-01 | 0.096 |
10528 | NOP56 | HTA11_6818_2000001021 | Human | Colorectum | AD | 1.32e-02 | 2.29e-01 | 0.0588 |
10528 | NOP56 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.02e-02 | 2.17e-01 | 0.294 |
10528 | NOP56 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 1.59e-03 | 1.10e+00 | 0.3487 |
10528 | NOP56 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.28e-22 | 1.10e+00 | 0.281 |
10528 | NOP56 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.17e-03 | 3.55e-01 | 0.3859 |
10528 | NOP56 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 1.80e-02 | 4.80e-01 | 0.2585 |
10528 | NOP56 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 2.43e-13 | 6.05e-01 | 0.3005 |
10528 | NOP56 | A001-C-119 | Human | Colorectum | FAP | 4.71e-04 | 5.58e-01 | -0.1557 |
10528 | NOP56 | A002-C-205 | Human | Colorectum | FAP | 7.53e-04 | 3.61e-01 | -0.1236 |
10528 | NOP56 | A015-C-006 | Human | Colorectum | FAP | 4.47e-07 | 5.88e-01 | -0.0994 |
10528 | NOP56 | A015-C-104 | Human | Colorectum | FAP | 4.92e-03 | 2.13e-01 | -0.1899 |
10528 | NOP56 | A002-C-116 | Human | Colorectum | FAP | 5.12e-03 | 9.57e-02 | -0.0452 |
10528 | NOP56 | F034 | Human | Colorectum | FAP | 4.00e-04 | 3.13e-01 | -0.0665 |
10528 | NOP56 | LZE4T | Human | Esophagus | ESCC | 7.31e-20 | 2.76e-01 | 0.0811 |
10528 | NOP56 | LZE5T | Human | Esophagus | ESCC | 8.36e-04 | 9.82e-02 | 0.0514 |
10528 | NOP56 | LZE7T | Human | Esophagus | ESCC | 4.68e-07 | 6.41e-01 | 0.0667 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0042254113 | Thyroid | PTC | ribosome biogenesis | 202/5968 | 299/18723 | 3.47e-37 | 5.47e-34 | 202 |
GO:0006364112 | Thyroid | PTC | rRNA processing | 156/5968 | 225/18723 | 5.58e-31 | 5.03e-28 | 156 |
GO:0016072112 | Thyroid | PTC | rRNA metabolic process | 160/5968 | 236/18723 | 5.68e-30 | 3.58e-27 | 160 |
GO:003447018 | Thyroid | PTC | ncRNA processing | 215/5968 | 395/18723 | 7.14e-21 | 1.22e-18 | 215 |
GO:00346608 | Thyroid | PTC | ncRNA metabolic process | 239/5968 | 485/18723 | 5.54e-16 | 4.26e-14 | 239 |
GO:002261334 | Thyroid | ATC | ribonucleoprotein complex biogenesis | 292/6293 | 463/18723 | 3.05e-39 | 9.63e-36 | 292 |
GO:004225434 | Thyroid | ATC | ribosome biogenesis | 203/6293 | 299/18723 | 3.63e-34 | 4.59e-31 | 203 |
GO:000636432 | Thyroid | ATC | rRNA processing | 157/6293 | 225/18723 | 9.02e-29 | 5.70e-26 | 157 |
GO:001607232 | Thyroid | ATC | rRNA metabolic process | 161/6293 | 236/18723 | 1.02e-27 | 5.89e-25 | 161 |
GO:003447021 | Thyroid | ATC | ncRNA processing | 216/6293 | 395/18723 | 3.14e-18 | 3.98e-16 | 216 |
GO:003466021 | Thyroid | ATC | ncRNA metabolic process | 240/6293 | 485/18723 | 2.03e-13 | 9.91e-12 | 240 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa05017 | Colorectum | AD | Spinocerebellar ataxia | 60/2092 | 143/8465 | 3.78e-06 | 4.35e-05 | 2.78e-05 | 60 |
hsa050171 | Colorectum | AD | Spinocerebellar ataxia | 60/2092 | 143/8465 | 3.78e-06 | 4.35e-05 | 2.78e-05 | 60 |
hsa050174 | Colorectum | MSS | Spinocerebellar ataxia | 60/1875 | 143/8465 | 7.14e-08 | 1.26e-06 | 7.71e-07 | 60 |
hsa050175 | Colorectum | MSS | Spinocerebellar ataxia | 60/1875 | 143/8465 | 7.14e-08 | 1.26e-06 | 7.71e-07 | 60 |
hsa050176 | Colorectum | MSI-H | Spinocerebellar ataxia | 33/797 | 143/8465 | 8.28e-07 | 1.49e-05 | 1.25e-05 | 33 |
hsa050177 | Colorectum | MSI-H | Spinocerebellar ataxia | 33/797 | 143/8465 | 8.28e-07 | 1.49e-05 | 1.25e-05 | 33 |
hsa050178 | Colorectum | FAP | Spinocerebellar ataxia | 37/1404 | 143/8465 | 2.94e-03 | 1.29e-02 | 7.86e-03 | 37 |
hsa050179 | Colorectum | FAP | Spinocerebellar ataxia | 37/1404 | 143/8465 | 2.94e-03 | 1.29e-02 | 7.86e-03 | 37 |
hsa0501728 | Esophagus | ESCC | Spinocerebellar ataxia | 94/4205 | 143/8465 | 6.77e-05 | 2.90e-04 | 1.48e-04 | 94 |
hsa0501736 | Esophagus | ESCC | Spinocerebellar ataxia | 94/4205 | 143/8465 | 6.77e-05 | 2.90e-04 | 1.48e-04 | 94 |
hsa0501710 | Liver | Cirrhotic | Spinocerebellar ataxia | 66/2530 | 143/8465 | 2.58e-05 | 2.15e-04 | 1.32e-04 | 66 |
hsa0501711 | Liver | Cirrhotic | Spinocerebellar ataxia | 66/2530 | 143/8465 | 2.58e-05 | 2.15e-04 | 1.32e-04 | 66 |
hsa0501721 | Liver | HCC | Spinocerebellar ataxia | 92/4020 | 143/8465 | 3.20e-05 | 1.88e-04 | 1.04e-04 | 92 |
hsa0501731 | Liver | HCC | Spinocerebellar ataxia | 92/4020 | 143/8465 | 3.20e-05 | 1.88e-04 | 1.04e-04 | 92 |
hsa0501725 | Oral cavity | OSCC | Spinocerebellar ataxia | 86/3704 | 143/8465 | 5.21e-05 | 2.08e-04 | 1.06e-04 | 86 |
hsa05017111 | Oral cavity | OSCC | Spinocerebellar ataxia | 86/3704 | 143/8465 | 5.21e-05 | 2.08e-04 | 1.06e-04 | 86 |
hsa0501726 | Oral cavity | LP | Spinocerebellar ataxia | 59/2418 | 143/8465 | 6.97e-04 | 3.46e-03 | 2.23e-03 | 59 |
hsa0501735 | Oral cavity | LP | Spinocerebellar ataxia | 59/2418 | 143/8465 | 6.97e-04 | 3.46e-03 | 2.23e-03 | 59 |
hsa0501720 | Prostate | BPH | Spinocerebellar ataxia | 55/1718 | 143/8465 | 3.63e-07 | 3.74e-06 | 2.32e-06 | 55 |
hsa05017110 | Prostate | BPH | Spinocerebellar ataxia | 55/1718 | 143/8465 | 3.63e-07 | 3.74e-06 | 2.32e-06 | 55 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NOP56 | SNV | Missense_Mutation | c.1405C>G | p.Pro469Ala | p.P469A | O00567 | protein_coding | tolerated(0.52) | benign(0) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
NOP56 | SNV | Missense_Mutation | c.673N>A | p.Glu225Lys | p.E225K | O00567 | protein_coding | deleterious(0) | benign(0.168) | TCGA-BH-A0B0-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | CR | |
NOP56 | insertion | Frame_Shift_Ins | novel | c.1597_1598insTTCTGTTGCGACC | p.Lys533IlefsTer17 | p.K533Ifs*17 | O00567 | protein_coding | TCGA-BH-A0HF-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | ||
NOP56 | SNV | Missense_Mutation | c.501G>A | p.Met167Ile | p.M167I | O00567 | protein_coding | deleterious(0.01) | possibly_damaging(0.759) | TCGA-JX-A3PZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD | |
NOP56 | SNV | Missense_Mutation | c.1418N>G | p.Glu473Gly | p.E473G | O00567 | protein_coding | deleterious(0.01) | benign(0.003) | TCGA-A6-5665-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
NOP56 | SNV | Missense_Mutation | rs781343694 | c.307N>A | p.Ala103Thr | p.A103T | O00567 | protein_coding | tolerated(0.06) | benign(0.053) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
NOP56 | SNV | Missense_Mutation | c.191N>T | p.Ala64Val | p.A64V | O00567 | protein_coding | tolerated(1) | benign(0.001) | TCGA-AD-6964-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | folfox | PD | |
NOP56 | SNV | Missense_Mutation | rs541896402 | c.1425N>A | p.Met475Ile | p.M475I | O00567 | protein_coding | tolerated(0.22) | benign(0) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NOP56 | SNV | Missense_Mutation | rs763810400 | c.1373N>T | p.Ala458Val | p.A458V | O00567 | protein_coding | tolerated(0.15) | probably_damaging(0.978) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
NOP56 | SNV | Missense_Mutation | novel | c.1486N>C | p.Met496Leu | p.M496L | O00567 | protein_coding | tolerated_low_confidence(0.45) | benign(0) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |